A new triple threat to CLL.
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-08-870808
Abstract: In this issue of Blood, Rogers et al demonstrate that 3 novel agents approved for chronic lymphocytic leukemia (CLL), ibrutinib, venetoclax, and obinutuzumab, can be safely combined at standard doses to create an active, chemotherapy-free… read more here.
Keywords: threat cll; new triple; triple threat;
COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12071119
Abstract: COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the pandemic, is also a hotbed with the highest death… read more here.
Keywords: covid mucormycosis; mucormycosis cancer; cancer triple; triple threat ... See more keywords